AnaptysBio reports preliminary cash & investments of ~$310M as of Dec 31, 2025

ANAPTYSBIO, INC

Preliminary unaudited cash, equivalents and investments ~$310M as of Dec 31, 2025.
Audited FY2025 financials not yet available; final results may differ materially.
Disclosure to be made at J.P. Morgan Healthcare Conference on January 11, 2026.

item 2.02 item 7.01 item 9.01

ANAPTYSBIO, INC filing history →

Source: SEC EDGAR

accession 0001370053-26-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.